Multistep Carcinogenesis: A Chain Reaction of Aneuploidizations

Carcinogenesis is a multistep process in which new, parasitic and polymorphic cancer cells evolve from a single, normal diploid cell. This normal cell is converted to a prospective cancer cell, alias "initiated", either by a carcinogen or spontaneously. The initiated cell typically does not have a new distinctive phenotype yet, but evolves spontaneously—over months to decades—to a clinical cancer. The cells of a primary cancer also evolve spontaneously towards more and more malignant phenotypes. The outstanding genotype of initiated and cancer cells is aneuploidy, an abnormal balance of chromosomes, which increases and varies in proportion with malignancy. The driving force of the spontaneous evolution of initiated and cancerous cells to ever more abnormal phenotypes is said to be their "genetic instability". However, since neither the instability of cancer phenotypes nor the characteristically slow kinetics of carcinogenesis are compatible with gene mutation, we propose here that the driving force of carcinogenesis is the inherent instability of aneuploid karyotypes. Aneuploidy renders chromosome structure and segregation error-prone, because it unbalances mitosis proteins and the many teams of enzymes that synthesize and maintain chromosomes. Thus, carcinogenesis is initiated by a random aneuploidy, which is induced either by a carcinogen or spontaneously. The resulting karyotype instability sets off a chain reaction of aneuploidizations, which generate ever more abnormal and eventually cancer-specific combinations and rearrangements of chromosomes. According to this hypothesis the many abnormal phenotypes of cancer are generated by abnormal dosages of thousands of aneuploid, but un-mutated genes.

[1]  O. Iversen The skin tumorigenic and carcinogenic effects of different doses, numbers of dose fractions and concentrations of 7,12-dimethylbenz[a]anthracene in acetone applied on hairless mouse epidermis. Possible implications for human carcinogenesis. , 1991, Carcinogenesis.

[2]  R. McAllister,et al.  Tumorigenicity of Tissue Culture Cells , 1959 .

[3]  A. Laat,et al.  Carcinogenesis induced by UVA (365-nm) radiation: the dose-time dependence of tumor formation in hairless mice , 1997 .

[4]  Nordling Co A New Theory on the Cancer-inducing Mechanism , 1953 .

[5]  W. Lijinsky A view of the relation between carcinogenesis and mutagenesis , 1989, Environmental and molecular mutagenesis.

[6]  Hongyue Dai,et al.  Widespread aneuploidy revealed by DNA microarray expression profiling , 2000, Nature Genetics.

[7]  B. Johansson,et al.  A breakpoint map of recurrent chromosomal rearrangements in human neoplasia , 1997, Nature Genetics.

[8]  H. Pilch,et al.  Evaluation of DNA ploidy and degree of DNA abnormality in benign and malignant melanocytic lesions of the skin using video imaging , 2000, Cancer.

[9]  Yudong D. He,et al.  Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.

[10]  C. Boone,et al.  Sarcomas routinely produced from putatively nontumorigenic Balb/3T3 and C3H/10T1/2 cells by subcutaneous inoculation attached to plastic platelets. , 1976, Journal of supramolecular structure.

[11]  N. Fusenig,et al.  Multiple stages and genetic alterations in immortalization, malignant transformation, and tumor progression of human skin keratinocytes , 1998, Molecular carcinogenesis.

[12]  N. B. Atkin Nuclear Size in Premalignant Conditions of the Cervix Uteri , 1964, Nature.

[13]  H. Kacser,et al.  The molecular basis of dominance. , 1981, Genetics.

[14]  M. Fox Fundamentals of Oncology , 1979, British Journal of Cancer.

[15]  A. Zetterberg,et al.  Cytomorphological grading and feulgen DNA‐analysis of metaplastic and neoplastic bronchial cells , 1978, Cancer.

[16]  Jeffrey K. Cohen,et al.  Origins and clinical implications of aneuploidy in early bladder cancer. , 1995, Cytometry.

[17]  L. Donehower,et al.  Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours , 1992, Nature.

[18]  J. Davies,et al.  Molecular Biology of the Cell , 1983, Bristol Medico-Chirurgical Journal.

[19]  R. Hay American Type Culture Collection catalogue of cell lines and hybridomas , 1985 .

[20]  Richard D. Wood,et al.  Human DNA Repair Genes , 2001, Science.

[21]  F. McCormick The polymerase chain reaction and cancer diagnosis. , 1989, Cancer cells.

[22]  F. Mertens,et al.  Karyotypic heterogeneity and clonal evolution in squamous cell carcinomas of the head and neck. , 2002, Cancer genetics and cytogenetics.

[23]  N. B. Atkin,et al.  Chromosome abnormalities as primary events in human malignant disease: evidence from marker chromosomes. , 1966, Journal of the National Cancer Institute.

[24]  W. Giaretti A model of DNA aneuploidization and evolution in colorectal cancer. , 1994, Laboratory investigation; a journal of technical methods and pathology.

[25]  H. Ribbert,et al.  Zur Frage der Entstehung maligner Tumoren , 1914, Naturwissenschaften.

[26]  M. Hamou,et al.  Cellular and tumoural heterogeneity of EGFR gene amplification in human malignant gliomas , 2005, Acta Neurochirurgica.

[27]  B. Johansson,et al.  Primary vs. secondary neoplasia‐associated chromosomal abnormalities—balanced rearrangements vs. genomic imbalances? , 1996, Genes, chromosomes & cancer.

[28]  C. Nordling A New Theory on the Cancer-inducing Mechanism , 1953, British Journal of Cancer.

[29]  P. Duesberg,et al.  Are Centrosomes or Aneuploidy the Key to Cancer? , 1999, Science.

[30]  J. Cairns The origin of human cancers , 1981, Nature.

[31]  B. Li,et al.  neu/ERBB2 cooperates with p53-172H during mammary tumorigenesis in transgenic mice , 1997, Molecular and cellular biology.

[32]  R. Monson,et al.  Breast cancer in women after repeated fluoroscopic examinations of the chest. , 1977, Journal of the National Cancer Institute.

[33]  Allan Balmain,et al.  Cancer genetics: from Boveri and Mendel to microarrays , 2001, Nature Reviews Cancer.

[34]  A. Plaja,et al.  Chromosome aneuploidy and cancer: lessons from a chromosomal instability syndrome. , 2001, Cancer genetics and cytogenetics.

[35]  Robert A. Weinberg,et al.  A checkpoint on the road to cancer , 1998, Nature.

[36]  R. Goldsby,et al.  Isolation and characterization of thymidine transport mutants of Chinese hamster cells. , 1969, Experimental cell research.

[37]  T. Webb When theories collide: experts develop different models for carcinogenesis. , 2001, Journal of the National Cancer Institute.

[38]  L. S. Cram,et al.  Spontaneous neoplastic evolution of Chinese hamster cells in culture: multistep progression of karyotype. , 1983, Cancer research.

[39]  P. Duesberg,et al.  Aneuploidy correlated 100% with chemical transformation of Chinese hamster cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[40]  Jean Marx,et al.  Debate Surges Over the Origins of Genomic Defects in Cancer , 2002, Science.

[41]  R. Pollack,et al.  Cancer biology. , 1978, Science.

[42]  B. S. Baker,et al.  Segmental aneuploidy and the genetic gross structure of the Drosophila genome. , 1972, Genetics.

[43]  P. Duesberg,et al.  Are cancers dependent on oncogenes or on aneuploidy? , 2003, Cancer genetics and cytogenetics.

[44]  K. Kinzler,et al.  The multistep nature of cancer. , 1993, Trends in genetics : TIG.

[45]  F. D. de Gruijl,et al.  Carcinogenesis induced by UVA (365-nm) radiation: the dose-time dependence of tumor formation in hairless mice. , 1997, Carcinogenesis.

[46]  L. I. Gardner Human Genetics: Problems and Approaches , 1981 .

[47]  S. Goodman,et al.  Evidence that genetic instability occurs at an early stage of colorectal tumorigenesis. , 2001, Cancer research.

[48]  K. Kinzler,et al.  Genetic instability in colorectal cancers , 1997, Nature.

[49]  K. Brand,et al.  Chromosomal Aberrations in Foreign Body Tumorigenesis of Mice 1 2 , 1983, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[50]  P. Rous Surmise and Fact on the Nature of Cancer , 1959, Nature.

[51]  P. Gosling DORLAND’S ILLUSTRATED MEDICAL DICTIONARY , 2003, Australasian Chiropractic & Osteopathy.

[52]  Olufunmilayo I. Olopade,et al.  The Chromosomes in Human Cancer and Leukemia , 1981 .

[53]  L. Hayflick THE LIMITED IN VITRO LIFETIME OF HUMAN DIPLOID CELL STRAINS. , 1965, Experimental cell research.

[54]  A. Aguilera,et al.  High levels of chromosome instability in polyploids of Saccharomyces cerevisiae. , 1990, Mutation research.

[55]  G. Yarrington Molecular Cell Biology , 1987, The Yale Journal of Biology and Medicine.

[56]  H. Höfler,et al.  Evaluation of C-ErbB-2 Overexpression and Her-2/neu Gene Copy Number Heterogeneity in Barrett’s Adenocarcinoma , 2000, Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology.

[57]  P. Armitage,et al.  The Age Distribution of Cancer and a Multi-stage Theory of Carcinogenesis , 1954, British Journal of Cancer.

[58]  T. Kunkel,et al.  Effects of altered nucleotide concentrations on the fidelity of DNA replication. , 1985, Basic life sciences.

[59]  P. Duesberg,et al.  Specific aneusomies in Chinese hamster cells at different stages of neoplastic transformation, initiated by nitrosomethylurea , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[60]  D. Kurnit Down syndrome: gene dosage at the transcriptional level in skin fibroblasts. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[61]  P. Duesberg,et al.  Aneuploidy vs. gene mutation hypothesis of cancer: recent study claims mutation but is found to support aneuploidy. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[62]  D. Bostwick,et al.  Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization. , 1997, Cancer research.

[63]  E. Schröck,et al.  Genomic changes defining the genesis, progression, and malignancy potential in solid human tumors: A phenotype/genotype correlation , 1999, Genes, chromosomes & cancer.

[64]  J. Little,et al.  Timing of the steps in transformation of C3H 10T½ cells by X-irradiation , 1984, Nature.

[65]  N. Konishi,et al.  Intratumor cellular heterogeneity and alterations in ras oncogene and p53 tumor suppressor gene in human prostate carcinoma. , 1995, The American journal of pathology.

[66]  A. Balmain,et al.  How many mutations are required for tumorigenesis? implications from human cancer data , 1993 .

[67]  A. Levan,et al.  Inverse relationship between chromosome ploidy and host-specificity of sixteen transplantable tumors☆ , 1953 .

[68]  J. Bishop Enemies within: the genesis of retrovirus oncogenes , 1981, Cell.

[69]  L. Foulds The experimental study of tumor progression: a review. , 1954, Cancer research.

[70]  J. Scribner,et al.  Tumor initiation and promotion. , 1978, International review of experimental pathology.

[71]  K Wheatley,et al.  The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. , 1998, Blood.

[72]  D. Hansemann Ueber asymmetrische Zelltheilung in Epithelkrebsen und deren biologische Bedeutung , 1890, Archiv für pathologische Anatomie und Physiologie und für klinische Medicin.

[73]  L. Old,et al.  Transforming ras genes from human melanoma: a manifestation of tumour heterogeneity? , 1984, Nature.

[74]  H. S. Thompson,et al.  Dorland's Illustrated Medical Dictionary, 26th ed , 1982 .

[75]  A. Cornish-Bowden Kinetics of Multi‐Enzyme Systems , 2001 .

[76]  Paul E Polani The Role of Chromosomes in Cancer Biology , 1974 .

[77]  M. Vogt,et al.  A genetic change in a tissue culture line of neoplastic cells. , 1958, Journal of cellular physiology. Supplement.

[78]  P. Walker Cancer—Science and Society , 1980, British Journal of Cancer.

[79]  S H Kim,et al.  Transgenic mouse models that explore the multistep hypothesis of intestinal neoplasia , 1993, The Journal of cell biology.

[80]  F T Bosman,et al.  Intratumor genetic heterogeneity in advanced human colorectal adenocarcinoma , 2001, International journal of cancer.

[81]  A. Bradley,et al.  Embryonic lethality and tumorigenesis caused by segmental aneuploidy on mouse chromosome 11. , 1998, Genetics.

[82]  Yuesheng Jin,et al.  Clonal chromosome abnormalities in premalignant lesions of the skin. , 2002, Cancer genetics and cytogenetics.

[83]  J. Ingle,et al.  Centrosome hypertrophy in human breast tumors: implications for genomic stability and cell polarity. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[84]  C. Epstein The Consequences of Chromosome Imbalance: Principles, Mechanisms, and Models , 1986 .

[85]  P. Duesberg,et al.  Aneuploidy precedes and segregates with chemical carcinogenesis. , 2000, Cancer genetics and cytogenetics.

[86]  L. Loeb,et al.  Mutator phenotype may be required for multistage carcinogenesis. , 1991, Cancer research.

[87]  P. Duesberg,et al.  How aneuploidy affects metabolic control and causes cancer. , 1999, The Biochemical journal.

[88]  Giovanni Parmigiani,et al.  Prevalence of somatic alterations in the colorectal cancer cell genome , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[89]  Harvey F. Lodish,et al.  MOLECULAR.CELL.BIOLOGY 5TH.ED , 2003 .

[90]  M. Stampfer,et al.  Chromosome analyses of human mammary epithelial cells at stages of chemical-induced transformation progression to immortality. , 1989, Cancer genetics and cytogenetics.

[91]  D. Haber,et al.  The promise of cancer genetics , 1998, The Lancet.

[92]  R. Stock,et al.  The sigmoidal curve of cancer , 2003, Nature Biotechnology.

[93]  P. Duesberg,et al.  Explaining the high mutation rates of cancer cells to drug and multidrug resistance by chromosome reassortments that are catalyzed by aneuploidy. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[94]  A. Böcking,et al.  Diagnostic and prognostic value of DNA cytometry in gynecologic cytology. , 1989, Analytical and quantitative cytology and histology.

[95]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[96]  International Human Genome Sequencing Consortium Initial sequencing and analysis of the human genome , 2001, Nature.

[97]  A. Sandberg,et al.  Chromosome Alterations and Oncogenes in Human Neoplasia , 1990 .

[98]  F. Waldman,et al.  ERBB-2 (HER2/neu) gene copy number, p185HER-2 overexpression, and intratumor heterogeneity in human breast cancer. , 1995, Cancer research.

[99]  M. Matzke,et al.  Rapid structural and epigenetic changes in polyploid and aneuploid genomes , 1999, BioEssays : news and reviews in molecular, cellular and developmental biology.

[100]  Robert A. Weinberg,et al.  Creation of human tumour cells with defined genetic elements , 1999, Nature.

[101]  B. Ponder,et al.  Molecular Genetics of Cancer , 1992, Nature Medicine.

[102]  C. Yue,et al.  Genome-wide search for loss of heterozygosity using laser capture microdissected tissue of breast carcinoma: an implication for mutator phenotype and breast cancer pathogenesis. , 2000, Cancer research.

[103]  A. Balmain,et al.  Genetic changes in skin tumor progression: Correlation between presence of a mutant ras gene and loss of heterozygosity on mouse chromosome 7 , 1990, Cell.

[104]  L. Franks Neoplastic development , 1976, Nature.

[105]  A. Meyers,et al.  Identification of individuals at high risk for head and neck carcinogenesis using chromosome aneuploidy detected by fluorescence in situ hybridization. , 1999, Mutation research.

[106]  William C Hahn,et al.  Rules for making human tumor cells. , 2002, The New England journal of medicine.

[107]  T. Hauschka Correlation of chromosomal and physiologic changes in tumors. , 1958, Journal of cellular physiology. Supplement.

[108]  Cori Bargmann,et al.  Mechanism of activation of a human oncogene , 1982, Nature.

[109]  W. Hahn,et al.  Derivation of human tumor cells in vitro without widespread genomic instability. , 2001, Cancer research.

[110]  P. Duesberg,et al.  Aneuploidy, the somatic mutation that makes cancer a species of its own. , 2000, Cell motility and the cytoskeleton.

[111]  F. Waldman,et al.  Heterogeneity, polyploidy, aneusomy, and 9p deletion in human glioblastoma multiforme. , 1995, Cancer genetics and cytogenetics.

[112]  D. Magennis Nuclear DNA in histological and cytological specimens: measurement and prognostic significance. , 1997, British journal of biomedical science.

[113]  Iscn International System for Human Cytogenetic Nomenclature , 1978 .

[114]  C. Purdie,et al.  Tumour incidence, spectrum and ploidy in mice with a large deletion in the p53 gene. , 1994, Oncogene.

[115]  Roger H. Reeves Recounting a genetic story , 2000, Nature.

[116]  P. Hieter,et al.  Polyploidy--More Is More or Less , 1999, Science.

[117]  I. Berenblum,et al.  An Experimental Study of the Initiating Stage of Carcinogenesis, and a Re-examination of the Somatic Cell Mutation Theory of Cancer , 1949, British Journal of Cancer.

[118]  T. Hassold Chromosome abnormalities in human reproductive wastage , 1986 .

[119]  P. Duesberg,et al.  Latent viruses and mutated oncogenes: no evidence for pathogenicity. , 1992, Progress in nucleic acid research and molecular biology.

[120]  R. Holliday Chromosome error propagation and cancer. , 1989, Trends in genetics : TIG.

[121]  J. Chin,et al.  Relationship between DNA ploidy, glandular differentiation, and tumor spread in human prostate cancer. , 1985, Cancer research.

[122]  W. Giaretti,et al.  Intratumor heterogeneity of K-ras2 mutations in colorectal adenocarcinomas: association with degree of DNA aneuploidy. , 1996, The American journal of pathology.

[123]  A. Reith,et al.  Specific gain of chromosome 19 in preneoplastic mouse liver cells after diethylnitrosamine treatment. , 1991, Carcinogenesis.

[124]  J. Barrett,et al.  Chemically induced aneuploidy in mammalian cells: mechanisms and biological significance in cancer. , 1986, Environmental mutagenesis.

[125]  K. Bayreuther Chromosomes in Primary Neoplastic Growth , 1960, Nature.

[126]  L. Sachs,et al.  Identification of a chromosome that controls malignancy in chinese hamster cells , 1977, Journal of cellular physiology.

[127]  S. Corsale,et al.  DNA aneuploidy and high proliferative activity but not K‐ras‐2 mutations as independent predictors of clinical outcome in operable gastric carcinoma , 2001, Cancer.

[128]  P. Carroll,et al.  Heterogeneity of erbB-2 gene amplification in bladder cancer. , 1993, Cancer research.

[129]  P. Duesberg,et al.  Origin of multidrug resistance in cells with and without multidrug resistance genes: Chromosome reassortments catalyzed by aneuploidy , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[130]  P. Nowell The clonal evolution of tumor cell populations. , 1976, Science.

[131]  C. Lengauer How do tumors make ends meet? , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[132]  P. Duesberg,et al.  Aneuploidy versus gene mutation as cause of cancer , 2001 .

[133]  F. Waldman,et al.  Genomic instability is an early event during the progression pathway of ulcerative-colitis-related neoplasia. , 1999, The American journal of pathology.

[134]  I. Weinstein Addiction to Oncogenes--the Achilles Heal of Cancer , 2002, Science.

[135]  Ian Tomlinson,et al.  Selection, the mutation rate and cancer: Ensuring that the tail does not wag the dog , 1999, Nature medicine.

[136]  H Knecht,et al.  Centrosome defects and genetic instability in malignant tumors. , 1998, Cancer research.

[137]  T J Horder,et al.  The cells of the body: a history of somatic cell genetics , 1997, Medical History.

[138]  P. Edwards,et al.  Spectral karyotyping suggests additional subsets of colorectal cancers characterized by pattern of chromosome rearrangement , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[139]  C. Keysser Neoplastic Development, Vol. 2 , 1976 .

[140]  J. Sudbø,et al.  DNA content as a prognostic marker in patients with oral leukoplakia. , 2001, The New England journal of medicine.

[141]  N. B. Atkin,et al.  Are human cancers ever diploid--or often trisomic? Conflicting evidence from direct preparations and cultures. , 1990, Cytogenetics and cell genetics.

[142]  D. Grimwade,et al.  The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial. , 2001, Blood.

[143]  Magennis Dp NUCLEAR DNA IN HISTOLOGICAL AND CYTOLOGICAL SPECIMENS: MEASUREMENT AND PROGNOSTIC SIGNIFICANCE , 1997 .

[144]  Christian A. Rees,et al.  Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[145]  F. Mitelman,et al.  Genetic convergence and divergence in tumor progression. , 1988, Cancer research.

[146]  P. Duesberg,et al.  Genetic instability of cancer cells is proportional to their degree of aneuploidy. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[147]  U. Ahlstrom Chromosomes of primary carcinomas induced by 7,12-dimethylbenz(a)anthracene in the rat. , 1974, Hereditas.

[148]  G. Barski,et al.  Characteristics of "hybrid"-type clonal cell lines obtained from mixed cultures in vitro. , 1962, Journal of the National Cancer Institute.

[149]  P. Blount,et al.  Flow-cytometric and histological progression to malignancy in Barrett's esophagus: prospective endoscopic surveillance of a cohort. , 1992, Gastroenterology.

[150]  N. B. Atkin,et al.  Possible differences between the karyotypes of preinvasive lesions and malignant tumours. , 1969, British Journal of Cancer.

[151]  P. Fialkow,et al.  Clonal origin of human tumors. , 1979, Annual review of medicine.

[152]  T. Hauschka The chromosomes in ontogeny and oncogeny. , 1961, Cancer research.

[153]  S. van der Flier,et al.  Analysis of N-ras mutations in human cutaneous melanoma: tumor heterogeneity detected by polymerase chain reaction/single-stranded conformation polymorphism analysis. , 1995, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[154]  Thomas J. Liesegang,et al.  Human DNA repair genes. Wood RD,∗ Mitchell M, Sgouros J, Lindahl T. Science 2001;291:1284–1289. , 2001 .

[155]  B. Strauss The origin of point mutations in human tumor cells. , 1992, Cancer research.

[156]  A. Levan,et al.  Specific chromosome changes in malignancy: studies in rat sarcomas induced by two polycyclic hydrocarbons. , 2009, Hereditas.

[157]  L. S. Cram,et al.  Karyotype instability of Chinese hamster cells during in vivo tumor progression , 1987, Somatic cell and molecular genetics.

[158]  P. Duesberg,et al.  Instability of chromosome structure in cancer cells increases exponentially with degrees of aneuploidy. , 2003, Cancer genetics and cytogenetics.

[159]  R H Hruban,et al.  Gene expression profiles in normal and cancer cells. , 1997, Science.

[160]  E. Huberman,et al.  Mutagenesis by chemical agents in V79 chinese hamster cells: a review and analysis of the literature. A report of the Gene-Tox Program. , 1981, Mutation research.

[161]  M. Kimmey,et al.  DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis. , 1992, Gastroenterology.

[162]  H. Kacser,et al.  MOlecular democracy: who shares the controls? , 1979, Biochemical Society transactions.

[163]  E. Tajara,et al.  Cytogenetic study of neoplastic and nonneoplastic cells of the skin. , 1995, Cancer genetics and cytogenetics.

[164]  P. Duesberg,et al.  Correspondence re: D. Zimonjic et al., Derivation of human tumor cells in vitro without widespread genomic instability. Cancer Res., 61: 8838-8844, 2001. , 2002, Cancer research.

[165]  K. Loeb,et al.  Multiple mutations and cancer , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[166]  C Lengauer,et al.  Genetic instability and darwinian selection in tumours. , 1999, Trends in cell biology.

[167]  C. Harris,et al.  Chemical and physical carcinogenesis: advances and perspectives for the 1990s. , 1991, Cancer research.

[168]  L. Deaven,et al.  On the nature of heteroploidy. , 1974, Cold Spring Harbor symposia on quantitative biology.

[169]  S. Lippman,et al.  Molecular markers of the risk of oral cancer. , 2001, The New England journal of medicine.

[170]  K. Haigis,et al.  Intestinal adenomas can develop with a stable karyotype and stable microsatellites , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[171]  B. Strauss The Stability of the Genome and the Genetic Instability of Tumors , 2000, Perspectives in biology and medicine.

[172]  B. Brinkley,et al.  Supernumerary centrosomes and cancer: Boveri's hypothesis resurrected. , 1998, Cell motility and the cytoskeleton.

[173]  A. Hanby,et al.  An inbred colony of oncogene transgenic mice: diversity of tumours and potential as a therapeutic model. , 1996, British Journal of Cancer.

[174]  M. Gershwin,et al.  Relationship between karyotype of tissue culture lines and tumorigenicity in nude mice. , 1984, Experimental cell biology.

[175]  I. Purchase,et al.  Reflections on the declining ability of the Salmonella assay to detect rodent carcinogens as positive. , 1988, Mutation research.

[176]  I. Yaniv,et al.  Molecular cytogenetic parameters in Ewing sarcoma. , 2003, Cancer genetics and cytogenetics.

[177]  Y. Nakamura,et al.  Genetic alterations during colorectal-tumor development. , 1988, The New England journal of medicine.

[178]  J. Barrett,et al.  Tumour promoters induce mitotic aneuploidy in yeast , 1981, Nature.

[179]  F. Miller,et al.  The cellular basis of tumor progression. , 1998, International review of cytology.

[180]  B. Dutrillaux,et al.  Near haploidy in breast cancer: a particular pathway of chromosome evolution. , 1998, Cancer genetics and cytogenetics.